The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
Open accessAbstract
Because Berkeley sickle cell mice are used as an animal model for human sickle cell disease, we investigated the progression of the histopathology in these animals over 6 months and compared these findings to those published in humans with sickle cell disease. The murine study groups were composed of wild-type mixed C57Bl/6-SV129 (control) mice and sickle cell (SS) mice (alpha-/-, beta-/-, transgene +) of both sexes and between 1 and 6 months of age. SS mice were similar to humans with sickle cell disease in having erythrocytic sickling, vascular ectasia, intravascular hemolysis, exuberant hematopoiesis, cardiomegaly, glomerulosclerosis, visceral congestion, hemorrhages, multiorgan infarcts, pyknotic neurons, and progressive siderosis. Cerebral perfusion studies demonstrated increased blood-brain barrier permeability in SS mice. SS mice differed from humans with sickle cell disease in having splenomegaly, splenic hematopoiesis, more severe hepatic infarcts, less severe pulmonary manifestations, no significant vascular intimal hyperplasia, and only a trend toward vascular medial hypertrophy. Early retinal degeneration caused by a homozygous mutation (rd1) independent from that causing sickle hemoglobin was an incidental finding in some Berkeley mice. While our study reinforces the fundamental strength of this model, the notable differences warrant careful consideration when drawing parallels to human sickle cell disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Young sickle mice do not commonly develop large-vessel vasculopathy and stroke (153, 154)”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234
Self-citationRetinal degeneration mutants in the mouse
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., & Heckenlively, J. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00146-8 · Cited by 840
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Pittler, S. J., & Baehr, W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8322 · Cited by 562
Differential effect of the rd mutation on rods and cones in the mouse retina.
Carter‐Dawson, L. D., LaVail, M. M., & Sidman, R. L. (1978) · PubMed · Cited by 495
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Self-citationOcclusion of Large Cerebral Vessels in Sickle-Cell Anemia
STOCKMAN, J. A., Nigro, M. A., Mishkin, M. M., & Oski, F. A. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871703 · Cited by 333
Transgenic sickle mice have vascular inflammation
Belcher, J. D., Bryant, C. J., Nguyen, J., Bowlin, P. R., Kielbik, M. C., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2003) · Blood · doi:10.1182/blood-2002-10-3313 · Cited by 240
Sickle cell anemia and central nervous system infarction: A neuropathological study
Rothman, S. M., Fulling, K. H., & Nelson, J. S. (1986) · Annals of Neurology · doi:10.1002/ana.410200606 · Cited by 228
Merkel, K. H., Ginsberg, P. L., Parker, J. C., & Post, M. J. (1978) · Stroke · doi:10.1161/01.str.9.1.45 · Cited by 216
Sickle-Cell Hemoglobin and Its Relation to Fundus Abnormality
WELCH, R. B., & GOLDBERG, M. F. (1966) · Archives of Ophthalmology · doi:10.1001/archopht.1966.00970050355008 · Cited by 164
The liver in sickle cell disease
Bauer, T. W., Moore, G. W., & Hutchins, G. M. (1980) · The American Journal of Medicine · doi:10.1016/s0002-9343(80)80008-8 · Cited by 146
Acute infarction of long bones in children with sickle cell anemia
Keeley, K., & Buchanan, G. R. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80111-x · Cited by 128
A New Technique for Visualization of the Human Retinal Vasculature
Lutty, G. A. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140123039 · Cited by 119
Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia
de Jong, K., Emerson, R. K., Butler, J. T., Bastacky, J., Mohandas, N., & Kuypers, F. A. (2001) · Blood · doi:10.1182/blood.v98.5.1577 · Cited by 118
Mankad, V. N., Williams, J. P., Harpen, M. D., Manci, E. A., Longenecker, G. L., Moore, R., Shah, A. K., Ym, Y., & Brogdon, B. (1990) · Blood · doi:10.1182/blood.v75.1.274.274 · Cited by 114
Self-citationClinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia
Gerry, J. L., Bulkley, B. H., & Hutchins, G. M. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90902-5 · Cited by 112
The Lung in Sickle Cell Disease
Haupt, H. M., Moore, G. W., Bauer, T. W., & Hutchins, G. M. (1982) · CHEST Journal · doi:10.1378/chest.81.3.332 · Cited by 111
Stroke risk in siblings with sickle cell anemia
Driscoll, M. C. (2003) · Blood · doi:10.1182/blood.v101.6.2401 · Cited by 108
Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood
Stevens, M. C. G., Hayes, R., Vaidya, S., & Serjeant, G. R. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80529-x · Cited by 89
Histopathology of sickle cell retinopathy.
Romayanada, N., Mf, G., & Green, W. R. (1974) · PubMed · Cited by 86
Myocardial infarction in sickle cell disease.
Martin, C. R., Johnson, C. S., Cobb, C., Tatter, D., & Haywood, L. J. (1996) · PubMed Central · Cited by 81
Renal Lesions in Sickle Cell Nephropathy in Children
Tejani, A. H., Phadke, K., Adamson, O., Nicastri, A. D., Chen, C. K., & Sen, D. K. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183404 · Cited by 78
Pathological spectrum of liver diseases in sickle cell disease
Omata, M., Johnson, C. S., Tong, M. J., & Tatter, D. (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01318115 · Cited by 75
(1990) · PubMed · Cited by 68
Second generation knockout sickle mice: the effect of HbF
Fabry, M. E., Suzuka, S. M., Weinberg, R. S., Lawrence, C., Factor, S. M., Gilman, J. G., Costantini, F. D., & Nagel, R. L. (2001) · Blood · doi:10.1182/blood.v97.2.410 · Cited by 59
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease
Kean, L. S., Manci, E. A., Perry, J., Balkan, C., Coley, S. M., Holtzclaw, D., Adams, A. B., Larsen, C. P., Hsu, L. L.-Y., & Archer, D. R. (2003) · Blood · doi:10.1182/blood-2003-03-0712 · Cited by 58
Self-citationSTUDIES IN SICKLE CELL ANEMIA. XXI. CLINICO-PATHOLOGICAL ASPECTS OF NEUROLOGICAL MANIFESTATIONS.
Baird, R. L., Weiss, D. L., Ferguson, A. D., French, J. H., & Scott, R. B. (1964) · PubMed · Cited by 56
Zhang, Z., Davies, K., Prostak, J., Fenstermacher, J. D., & Chopp, M. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199901000-00008 · Cited by 52
Saxena, U. H., Scott, R. B., & Ferguson, A. D. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80323-2 · Cited by 48
EARLY SPLENOMEGALY IN HOMOZYGOUS SICKLE-CELL DISEASE: AN INDICATOR OF SUSCEPTIBILITY TO INFECTION
Rogers, D. W. O., Vaidya, S., & Serjeant, G. R. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92527-8 · Cited by 46
Histopathologic features of liver biopsy specimens in sickle cell disease.
Mills, L. R., Mwakyusa, D. H., & Milner, P. (1988) · PubMed · Cited by 44
Evolution of the retinal black sunburst in sickling haemoglobinopathies.
Asdourian, G. K., Nagpal, K. C., Goldbaum, M. H., Patrianakos, D., Goldberg, M. F., & Rabb, M. F. (1975) · British Journal of Ophthalmology · doi:10.1136/bjo.59.12.710 · Cited by 43
Glomerular Lesions in Sickle Cell Nephropathy
Walker, B. R. (1971) · JAMA · doi:10.1001/jama.1971.03180160037009 · Cited by 41
Early renal changes in sickle cell anemia.
Pitcock, J. A., MUIRHEAD, E. E., Hatch, F. E., Jg, J., & Bj, K. (1970) · PubMed · Cited by 37
Pathology of Sickle Cell Disease.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-5-821 · Cited by 37
Mankad, V., Williams, J. P., Harpen, M., et al. (1990) · Blood · doi:10.1182/blood.v75.1.274.bloodjournal751274 · Cited by 37
Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias
Pászty, C. (1997) · Current Opinion in Hematology · doi:10.1097/00062752-199704020-00003 · Cited by 34
Noguchi, C. T., Gladwin, M. T., Diwan, B. A., Merciris, P., Smith, R. D., Yu, X., Buzard, G. S., Fitzhugh, A. L., Keefer, L. K., Schechter, A. N., et al. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0469 · Cited by 26
Internal Carotid Artery Occlusion in a Child with Sickle Cell Disease
Tuohy, A. M. M., McKie, V. C., Manci, E. A., & Adams, R. J. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00009 · Cited by 25
Self-citationSickle cell glomerulopathy with focal segmental glomerulosclerosis.
Verani, R. R., & Conley, S. B. (1991) · PubMed · Cited by 22
Renal Pathology in Hemizygous Sickle Cell Mice
Diwan, B. A., Gladwin, M. T., Noguchi, C. T., Ward, J. M., Fitzhugh, A. L., & Buzard, G. S. (2002) · Toxicologic Pathology · doi:10.1080/019262302753559597 · Cited by 18
Renal pathology in adults over 40 with sickle-cell disease.
Morgan, A. G., Dj, S., & Williams, W. (1987) · PubMed · Cited by 16
Perivascular Fibrosis in the Bone Marrow in Sickle Cell Disease
Manci, E. A., Culberson, D. E., Gardner, J. M., Brogdon, B. G., Shah, A. K., Holladay, J. E., Powell, R. W., & Mankad, V. N. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-634-pfitbm · Cited by 11
Self-citationMagnetic Resonance Imaging of Bone Marrow in Sickle Cell Patients
Mankad, V. N., Yang, Y., Williams, J. P., & Brogdon, B. G. (1988) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-198824000-00016 · Cited by 10
Pathology of Sickle Cell Disease.
Fairbanks, V. F. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.03650060157036 · Cited by 9
Glomerular lesions in sickle cell nephropathy
Walker, B. R. (1971) · JAMA · doi:10.1001/jama.215.3.437 · Cited by 7
Research works printed but not linked: 4
- [12]12. Fabry ME, Suzuka SM, Aggarwal S, Nagel RL. Unexpected impact of HbF on mean survival time of BERK sickle transgenic mice expressing exclu- sively human hemoglobins [abstract]. Blood. 2002;100:2617a.
- [13]13. Noguchi CT, Gladwin MT, Diwan B, et al. Devel- oping a useful model for sickle cell disease: hem- izygotes for the mouse beta-globin gene [abstract]. Blood. 2000;96:598a.
- [30]30. Hardison JE, Rogers CM. Cardiovascular mani- festations of sickle cell anemia. In: Hurst JW, ed. The Heart. New York, NY: McGraw-Hill; 1979: 195.
- [41]41. Rothman S, Nelson JS. Stenosis of large caliber intracranial arteries and cerebral infarctions in sickle cell anaemia. Lab Invest. 1978;38:392.
Cited by
Sorted by citations
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Yazdanbakhsh, K., Ware, R. E., & Pirenne, F. (2012) · Blood · doi:10.1182/blood-2011-11-327361 · Cited by 406
Sickle cell disease: old discoveries, new concepts, and future promise
Frenette, P. S., & Atweh, G. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30920 · Cited by 416
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
Belcher, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26857 · Cited by 267
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Self-citation
Metadata
- Authors
- Manci, E. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Manci, E. A.
- ORCID
- Manci, E. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-02-15
- Volume
- 107
- Issue
- 4
- Pages
- 1651-1658
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1895417
- OpenAlex
- W2066774936
- Cited by
- 149
- References
- 48
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 2 · 2023: 11 · 2022: 8 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 5 · 2012: 5
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stony Brook University
- National Institutes of Health (n01hb007086-007)
- National Heart, Lung, and Blood Institute (P01HL044612, HL70981, HL 19278, N0-1-HB07086, R01HL070981, HL-44612, HL45922, R01HL019278, R01HL045922)
- National Institute of Neurological Disorders and Stroke (NS 43324, R01NS043324)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sickle cell disease, animal models, histopathology, angiodysplasia, intravascular hemolysis, cardiomegaly, glomerulosclerosis, splenomegaly, retinal degeneration, siderosis
- MeSH terms
- Anemia, Sickle Cell, Animals, Body Weight, Humans, Mutation, Organ Size, Reference Values, Species Specificity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
